Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3034% below fair value
$8.80+0.11 (+1.27%)
Close on Nov 13, 2026Market cap $1.60BP/E –Yield –
Teladoc Health gross margin
Gross margin is gross profit as a percentage of revenue.
Teladoc Health's gross margin for the twelve months ending Sep 30, 2026 was 68.6%. For fiscal 2025 it was 69.5%, against 70.8% the year before. The highest annual figure on record is 79.0% in fiscal 2013.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 69.5% | −1.3 |
| FY2024 | Dec 31, 2024 | 70.8% | −0.0 |
| FY2023 | Dec 31, 2023 | 70.8% | +1.7 |
| FY2022 | Dec 31, 2022 | 69.1% | +1.1 |
| FY2021 | Dec 31, 2021 | 68.0% | +3.7 |
| FY2020 | Dec 31, 2020 | 64.3% | −2.4 |
| FY2019 | Dec 31, 2019 | 66.7% | −2.5 |
| FY2018 | Dec 31, 2018 | 69.2% | −4.4 |
| FY2017 | Dec 31, 2017 | 73.6% | −0.5 |
| FY2016 | Dec 31, 2016 | 74.0% | +1.2 |
| FY2015 | Dec 31, 2015 | 72.8% | −4.4 |
| FY2014 | Dec 31, 2014 | 77.2% | −1.8 |
| FY2013 | Dec 31, 2013 | 79.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 68.6% | −1.6 |
| Q2 FY2026 | Jun 30, 2026 | 68.6% | −1.3 |
| Q1 FY2026 | Mar 31, 2026 | 67.8% | −0.9 |
| Q4 FY2025 | Dec 31, 2025 | 69.3% | −1.2 |
| Q3 FY2025 | Sep 30, 2025 | 70.1% | −1.8 |
| Q2 FY2025 | Jun 30, 2025 | 69.8% | −0.9 |
| Q1 FY2025 | Mar 31, 2025 | 68.7% | −1.2 |
| Q4 FY2024 | Dec 31, 2024 | 70.5% | −0.2 |
| Q3 FY2024 | Sep 30, 2024 | 71.9% | +0.1 |
| Q2 FY2024 | Jun 30, 2024 | 70.7% | −0.1 |
| Q1 FY2024 | Mar 31, 2024 | 69.9% | +0.1 |
| Q4 FY2023 | Dec 31, 2023 | 70.7% | +0.3 |
| Q3 FY2023 | Sep 30, 2023 | 71.8% | +2.2 |
| Q2 FY2023 | Jun 30, 2023 | 70.8% | +1.6 |
| Q1 FY2023 | Mar 31, 2023 | 69.8% | +2.9 |
| Q4 FY2022 | Dec 31, 2022 | 70.4% | +2.0 |
| Q3 FY2022 | Sep 30, 2022 | 69.6% | +2.0 |
| Q2 FY2022 | Jun 30, 2022 | 69.2% | +1.1 |
| Q1 FY2022 | Mar 31, 2022 | 66.9% | −0.9 |
| Q4 FY2021 | Dec 31, 2021 | 68.4% | +0.5 |
| Q3 FY2021 | Sep 30, 2021 | 67.6% | +3.9 |
| Q2 FY2021 | Jun 30, 2021 | 68.1% | +5.8 |
| Q1 FY2021 | Mar 31, 2021 | 67.8% | +7.9 |
| Q4 FY2020 | Dec 31, 2020 | 67.9% | +3.3 |
| Q3 FY2020 | Sep 30, 2020 | 63.7% | −5.2 |
| Q2 FY2020 | Jun 30, 2020 | 62.3% | −5.7 |
| Q1 FY2020 | Mar 31, 2020 | 60.0% | −5.3 |
| Q4 FY2019 | Dec 31, 2019 | 64.6% | −2.8 |
| Q3 FY2019 | Sep 30, 2019 | 69.0% | −0.2 |
| Q2 FY2019 | Jun 30, 2019 | 68.0% | −2.7 |
| Q1 FY2019 | Mar 31, 2019 | 65.3% | −4.8 |
| Q4 FY2018 | Dec 31, 2018 | 67.4% | −3.2 |
| Q3 FY2018 | Sep 30, 2018 | 69.2% | −6.4 |
| Q2 FY2018 | Jun 30, 2018 | 70.7% | −6.8 |
| Q1 FY2018 | Mar 31, 2018 | 70.0% | −1.7 |
| Q4 FY2017 | Dec 31, 2017 | 70.6% | −2.6 |
| Q3 FY2017 | Sep 30, 2017 | 75.6% | – |
| Q2 FY2017 | Jun 30, 2017 | 77.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 71.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 73.2% | – |
See a number that looks wrong?